Work

A Phase I Multi-Institutional Study of Systemic Sorafenib in Conjunction with Regional Melphalan for In-Transit Melanoma of the Extremity

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-012-2373-8

Authors: G. M. Beasley, A. P. Coleman, A. Raymond, G. Sanders, M. A. Selim, B. L. Peterson, M. S. Brady, M. A. Davies, C. Augustine, D. S. Tyler

Institutions: Duke University, Duke Medical Center, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Durham VA Medical Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Melanoma Research Alliance, National Cancer Institute, National Center for Research Resources

Awards: Duke CTSI, G5845118822, Translational Research in Surgical Oncology

OpenAlex ID: W2120507692

FWCI: 1.106

Cites: 41

Cited by: 21

Related to: 10